These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs. Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076 [TBL] [Abstract][Full Text] [Related]
3. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle. Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479 [TBL] [Abstract][Full Text] [Related]
4. Site of the muscle cell abnormality in swine susceptible to malignant hyperpyrexia. Okumura F; Crocker BD; Denborough MA Br J Anaesth; 1980 Apr; 52(4):377-83. PubMed ID: 7378237 [TBL] [Abstract][Full Text] [Related]
6. The effect of azumolene on hypercontractility and sarcoplasmic reticulum Ca(2+)-dependent ATPase activity of malignant hyperpyrexia-susceptible porcine skeletal muscle. Foster PS; Hopkinson KC; Payne N; Denborough MA Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):489-95. PubMed ID: 1833102 [TBL] [Abstract][Full Text] [Related]
7. Effect of diltiazem and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible porcine skeletal muscle. Foster PS; Denborough MA Br J Anaesth; 1989 May; 62(5):566-72. PubMed ID: 2730830 [TBL] [Abstract][Full Text] [Related]
8. Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle. Foster PS; Hopkinson KC; Denborough MA Clin Exp Pharmacol Physiol; 1989 Oct; 16(10):799-805. PubMed ID: 2612062 [TBL] [Abstract][Full Text] [Related]
9. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle. Anderson IL; Jones EW Anesthesiology; 1976 Jan; 44(1):57-61. PubMed ID: 1244776 [TBL] [Abstract][Full Text] [Related]
10. Temperature dependence of muscle function in malignant hyperpyrexia-susceptible swine. Sullivan JS; Denborough MA Br J Anaesth; 1981 Nov; 53(11):1217-22. PubMed ID: 7326167 [TBL] [Abstract][Full Text] [Related]
11. The pharmacology of clodanolene sodium, a new skeletal muscle contraction antagonist. Ellis KO; Wessels FL Arzneimittelforschung; 1978; 28(7):1100-5. PubMed ID: 582696 [TBL] [Abstract][Full Text] [Related]
13. The control of muscle contracture by the action of dantrolene on the sarcolemma. Halsall PJ; Ellis FR Acta Anaesthesiol Scand; 1983 Jun; 27(3):229-32. PubMed ID: 6880584 [TBL] [Abstract][Full Text] [Related]
14. Effect of dantrolene sodium on calcium movements in single muscle fibres. Hainaut K; Desmedt JE Nature; 1974 Dec; 252(5485):728-30. PubMed ID: 4548159 [No Abstract] [Full Text] [Related]
15. The pathopharmacology of malignant hyperpyrexia. Denborough MA Pharmacol Ther; 1980; 9(3):357-65. PubMed ID: 6997892 [No Abstract] [Full Text] [Related]
19. The effect of EU4093 (azumolene sodium) on the contraction of intrafusal muscle in the soleus muscle of the anaesthetized rat. Leslie GC; Part NJ Br J Pharmacol; 1989 Aug; 97(4):1151-6. PubMed ID: 2790379 [TBL] [Abstract][Full Text] [Related]
20. Effects of dantrolene on the diaphragm muscle of the normal and myopathic hamster. Langeron O; Coirault C; Fratea S; Orliaguet G; Coriat P; Riou B Br J Anaesth; 1998 Oct; 81(4):553-5. PubMed ID: 9924231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]